RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: acquired immunodeficiency syndrome
Accession: DOID:635
browse the term
Definition: A Human immunodeficiency virus infectious disease that results_in reduction in the numbers of CD4-bearing helper T cells below 200 per microliter of blood or 14% of all lymphocytes thereby rendering the subject highly vulnerable to life-threatening infections and cancers, has_material_basis_in Human immunodeficiency virus 1 or has_material_basis_in Human immunodeficiency virus 2, which are transmitted_by sexual contact, transmitted_by transfer of blood, semen, vaginal fluid, pre-ejaculate, or breast milk, transmitted_by congenital method, and transmitted_by contaminated needles. Opportunistic infections are common in people with AIDS. (DO)
Synonyms: exact_synonym: AIDS; Acquired Immune Deficiency Syndrome; Acquired Immuno Deficiency Syndrome; Acquired Immunodeficiency Syndromes; acquired immune deficiency; acquired immuno-deficiency syndromes; acquired immunologic deficiency syndrome
narrow_synonym: AIDS-related disease; acquired immunodeficiency syndrome, delayed progression to; acquired immunodeficiency syndrome, rapid progression to; acquired immunodeficiency syndrome, slow progression to
primary_id: MESH:D000163
xref: EFO:0000765 ; EFO:0009528 ; NCI:C2851
For additional species annotation, visit the
Alliance of Genome Resources .
G
Abcb1a
ATP-binding cassette, sub-family B member 1A
treatment
ISO
DNA:haplotype: :3435T>C((rs1045642), 2677T>G (rs2032582) (human) DNA:SNP: : rs10276036(human)
RGD
PMID:23372834 PMID:24517233
RGD:39456119 , RGD:11098698
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
G
Arhgap44
Rho GTPase activating protein 44
disease_progression
ISO
DNA:SNPs, haplotype:intron, exon: (rs2072255, rs2072254) (human) DNA:SNP:intron: (rs2072255) (human)
RGD
PMID:28069446 PMID:21107268
RGD:401901288 , RGD:401901289
NCBI chr11:64,892,865...65,053,779
Ensembl chr11:64,892,865...65,053,787
G
Bst2
bone marrow stromal cell antigen 2
ISO
DNA:SNPs: :
RGD
PMID:26885809
RGD:14398494
NCBI chr 8:71,986,899...71,990,116
Ensembl chr 8:71,986,899...71,990,100
G
Ccl4
C-C motif chemokine ligand 4
ISO
DNA:SNP:3' utr:rs1719153 (human)
RGD
PMID:16773571
RGD:5683896
NCBI chr11:83,553,410...83,555,509
Ensembl chr11:83,553,410...83,555,509
G
Ccr5
C-C motif chemokine receptor 5
ISO
ClinVar Annotator: match by term: Acquired immunodeficiency syndrome, delayed progression to
ClinVar
PMID:9742978 PMID:12610055 PMID:12815099 PMID:25741868
NCBI chr 9:123,921,557...123,934,153
Ensembl chr 9:123,921,580...123,947,736
G
Cd209d
CD209d antigen
disease_progression
ISO
associated with factor VIII deficiency; DNA:SNP:promoter: g.-139C>T (rs2287886) (human)
RGD
PMID:17530998
RGD:39939010
NCBI chr 8:3,921,824...3,928,548
Ensembl chr 8:3,921,824...3,928,555
G
Cd40lg
CD40 ligand
treatment
IMP
RGD
PMID:9499800
RGD:11344976
NCBI chr X:56,257,448...56,269,402
Ensembl chr X:56,257,503...56,269,402
G
Ercc2
excision repair cross-complementing rodent repair deficiency, complementation group 2
susceptibility
ISO
DNA:polymorphism:exon:p.K751Q(human)
RGD
PMID:20127180
RGD:5688740
NCBI chr 7:19,115,942...19,129,619
Ensembl chr 7:19,115,935...19,129,619
G
H2-Q1
histocompatibility 2, Q region locus 1
susceptibility
ISO
DNA:polymorphism: :HLA-A31
RGD
PMID:19030725
RGD:36049809
NCBI chr17:35,539,503...35,547,118
Ensembl chr17:35,539,381...35,544,075
G
Ido1
indoleamine 2,3-dioxygenase 1
ISO
associated with pulmonary tuberculosis;protein:increased expression:blood (human)
RGD
PMID:32369456
RGD:39939073
NCBI chr 8:25,074,148...25,086,987
Ensembl chr 8:25,074,152...25,087,025
G
Ifna1
interferon alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9612607
NCBI chr 4:88,768,324...88,768,893
Ensembl chr 4:88,768,324...88,768,893
G
Ifng
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Acquired immunodeficiency syndrome, rapid progression to
CTD ClinVar
PMID:9612607 PMID:12854077
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
G
Igf2
insulin-like growth factor 2
ISO
protein:decreased expression:plasma
RGD
PMID:11232005
RGD:5509969
NCBI chr 7:142,204,505...142,220,566
Ensembl chr 7:142,204,503...142,220,553
G
Il2
interleukin 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:9861562
NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108
G
Kir3dl1
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
severity
ISO
DNA:missense mutation:cds: p.I47V (rs643347) (human)
RGD
PMID:29461980
RGD:38676267
NCBI chr X:135,418,748...135,435,055
Ensembl chr X:135,418,748...135,435,058
G
Ncr1
natural cytotoxicity triggering receptor 1
ISO
protein:decreased expression:peripheral blood mononuclear cell,natural killer cell (human)
RGD
PMID:27382604
RGD:40818276
NCBI chr 7:4,340,714...4,348,183
Ensembl chr 7:4,340,723...4,348,163
G
Ncr3-ps
natural cytotoxicity triggering receptor 3, pseudogene
ISO
protein:decreased expression:peripheral blood mononuclear cell,natural killer cell (human)
RGD
PMID:27382604
RGD:40818276
NCBI chr17:35,399,512...35,403,785
Ensembl chr17:35,399,511...35,403,638
G
Tnf
tumor necrosis factor
ISO
RGD
PMID:8548330
RGD:12904035
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Tnfrsf1a
tumor necrosis factor receptor superfamily, member 1a
ISO
RGD
PMID:8548330
RGD:12904035
NCBI chr 6:125,326,686...125,339,446
Ensembl chr 6:125,326,325...125,339,447
G
Tnfrsf1b
tumor necrosis factor receptor superfamily, member 1b
ISO
RGD
PMID:8548330
RGD:12904035
NCBI chr 4:144,938,938...144,973,453
Ensembl chr 4:144,940,033...144,973,440
G
Vdr
vitamin D (1,25-dihydroxyvitamin D3) receptor
ISO
GAD
PMID:15118671
RGD:1331525
NCBI chr15:97,752,308...97,806,177
Ensembl chr15:97,752,306...97,808,511
G
Adrb2
adrenergic receptor, beta 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27400929
NCBI chr18:62,310,784...62,313,052
Ensembl chr18:62,310,887...62,313,030
G
Epo
erythropoietin
treatment
ISO
RGD
PMID:20818790
RGD:10395393
NCBI chr 5:137,481,282...137,484,078
Ensembl chr 5:137,481,282...137,531,504
G
Gc
vitamin D binding protein
ISO
associated with HIV Infections;protein:increased expression:cerebrospinal fluid:
RGD
PMID:17929958
RGD:5509882
NCBI chr 5:89,565,370...89,605,757
Ensembl chr 5:89,565,381...89,605,757
G
Il1b
interleukin 1 beta
ISO
protein:increased expression:neocortex
RGD
PMID:17678975
RGD:1626641
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Insr
insulin receptor
severity
ISO
protein:increased expression:cerebrospinal fluid, plasma
RGD
PMID:22629383
RGD:10403033
NCBI chr 8:3,200,922...3,329,649
Ensembl chr 8:3,172,061...3,329,617
G
Irs1
insulin receptor substrate 1
severity
ISO
protein:decreased tyrosine phosphorylation:cerebrospinal fluid, leukocyte
RGD
PMID:22629383
RGD:10403033
NCBI chr 1:82,210,826...82,269,160
Ensembl chr 1:82,210,822...82,269,137
G
Nefl
neurofilament, light polypeptide
ISO
associated with HIV Seropositivity;protein:increased expression:plasma, CSF (human) protein:increased expression:CSF (human)
RGD
PMID:30105502 PMID:27400930
RGD:127284876 , RGD:127284885
NCBI chr14:68,321,312...68,326,544
Ensembl chr14:68,321,312...68,326,544
G
Npy
neuropeptide Y
severity
ISO
protein:increased expression:cerebrospinal fluid
RGD
PMID:8815163
RGD:10431910
NCBI chr 6:49,799,690...49,806,487
Ensembl chr 6:49,799,690...49,806,487
G
Oprm1
opioid receptor, mu 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27400929
NCBI chr10:6,708,593...6,988,209
Ensembl chr10:6,708,506...6,988,198
G
Pdgfb
platelet derived growth factor, B polypeptide
ISO
RGD
PMID:21368226
RGD:6482787
NCBI chr15:79,880,066...79,899,178
Ensembl chr15:79,880,075...79,899,178
G
Slc6a4
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
IMP
RGD
PMID:25404050
RGD:38676266
NCBI chr11:76,889,423...76,923,169
Ensembl chr11:76,889,429...76,923,166
G
Agtr1a
angiotensin II receptor, type 1a
IMP
RGD
PMID:2
RGD:1303381
NCBI chr13:30,520,339...30,566,850
Ensembl chr13:30,520,424...30,566,850
G
Agtr2
angiotensin II receptor, type 2
IDA
RGD
PMID:2
RGD:1303381
NCBI chr X:21,350,863...21,355,072
Ensembl chr X:21,350,783...21,355,403
G
Egf
epidermal growth factor
ISO
RGD
PMID:19357719
RGD:6906909
NCBI chr 3:129,471,223...129,548,971
Ensembl chr 3:129,471,214...129,548,965
G
Hp
haptoglobin
ISO
protein:increased expression:urine
RGD
PMID:19279121
RGD:11041816
NCBI chr 8:110,301,760...110,305,804
Ensembl chr 8:110,301,760...110,305,804
G
Mtor
mechanistic target of rapamycin kinase
IMP ISO
RGD
PMID:23678040 PMID:23678040
RGD:7245474 , RGD:7245474
NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140
G
Myh9
myosin, heavy polypeptide 9, non-muscle
ISO
protein:decreased expression:glomerulus
RGD
PMID:22313957
RGD:6903274
NCBI chr15:77,644,788...77,726,315
Ensembl chr15:77,644,787...77,726,375
G
Notch4
notch 4
ISO
protein: increased expression: kidney
RGD
PMID:20706108 PMID:20706108
RGD:6480788 , RGD:6480788
NCBI chr17:34,783,257...34,807,517
Ensembl chr17:34,783,242...34,807,477
G
Nphs1
nephrosis 1, nephrin
treatment
IEP
RGD
PMID:19188342 PMID:17229913
RGD:38596324 , RGD:38599164
NCBI chr 7:30,157,259...30,188,048
Ensembl chr 7:30,157,740...30,186,648
G
Klrk1
killer cell lectin-like receptor subfamily K, member 1
treatment
ISO
RGD
PMID:23018378
RGD:39018554
NCBI chr 6:129,587,286...129,600,863
Ensembl chr 6:129,587,286...129,600,827
G
Bcl2
B cell leukemia/lymphoma 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10861090
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
Cd4
CD4 antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9546790
NCBI chr 6:124,841,656...124,865,210
Ensembl chr 6:124,841,655...124,865,184
G
Tnfrsf8
tumor necrosis factor receptor superfamily, member 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9379333
NCBI chr 4:144,993,702...145,041,734
Ensembl chr 4:144,993,707...145,041,734
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all